Assembly Biosciences, Inc.ASMBNASDAQ
Loading
Year-over-year book value per share growth
Latest
-22.72%
↓ 233% vs avg
Percentile
P15
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
17.10%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -22.72% |
| Q3 2025 | 909.36% |
| Q2 2025 | -34.59% |
| Q1 2025 | -28.69% |
| Q4 2024 | 23.81% |
| Q3 2024 | -33.39% |
| Q2 2024 | 3.38% |
| Q1 2024 | -20.68% |
| Q4 2023 | -21.29% |
| Q3 2023 | -24.53% |
| Q2 2023 | -23.74% |
| Q1 2023 | -18.62% |
| Q4 2022 | -3.81% |
| Q3 2022 | -17.67% |
| Q2 2022 | -15.84% |
| Q1 2022 | -18.84% |
| Q4 2021 | -23.76% |
| Q3 2021 | -8.81% |
| Q2 2021 | -13.24% |
| Q1 2021 | 2.77% |
| Q4 2020 | -20.43% |
| Q3 2020 | 0.72% |
| Q2 2020 | 5.41% |
| Q1 2020 | -7.85% |
| Q4 2019 | 28.97% |
| Q3 2019 | -11.02% |
| Q2 2019 | -8.50% |
| Q1 2019 | -10.20% |
| Q4 2018 | -10.44% |
| Q3 2018 | 112.61% |
| Q2 2018 | -14.28% |
| Q1 2018 | -9.49% |
| Q4 2017 | 106.02% |
| Q3 2017 | -16.75% |
| Q2 2017 | -17.08% |
| Q1 2017 | -15.21% |
| Q4 2016 | -11.30% |
| Q3 2016 | -10.46% |
| Q2 2016 | -7.98% |
| Q1 2016 | -7.96% |